首页|期刊导航|肿瘤学创新(英文)|The Efficacy and Safety of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Children With Osteosarcoma:A Retrospective Real-World Study

The Efficacy and Safety of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Children With Osteosarcoma:A Retrospective Real-World StudyOA

The Efficacy and Safety of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Children With Osteosarcoma:A Retrospective Real-World Study

Guoqi Wang;Suoqin Tang;Lina Chai;Yan Liang;Tongtong Li;Wenzhi Bi;Chen Feng

Senior Department of Pediatrics,The Seventh Medical Center of Chinese PLA General Hospital,Beijing,ChinaDepartment of Pediatrics,The First Medical Center of Chinese PLA General Hospital,Beijing,ChinaDepartment of Pediatrics,The First Medical Center of Chinese PLA General Hospital,Beijing,ChinaDepartment of Pediatrics,The First Medical Center of Chinese PLA General Hospital,Beijing,ChinaSenior Department of Pediatrics,The Seventh Medical Center of Chinese PLA General Hospital,Beijing,ChinaDepartment of Pediatrics,The First Medical Center of Chinese PLA General Hospital,Beijing,ChinaDepartment of Orthopedics,Tianjin Hospital,Tianjin,China

childrenefficacyneoadjuvant chemotherapyosteosarcomareal world

childrenefficacyneoadjuvant chemotherapyosteosarcomareal world

《肿瘤学创新(英文)》 2025 (2)

42-49,8

Tianjin Applied Basic Research Multi-Input Foundation(Tianjin Natural Science Foundation)(Grant No.:21JCQNJC01360).

10.1002/cai2.162

评论